J. Chris Houchins Becomes Medical Affairs SVP at Delcath (DCTH)
Up)
Delcath Systems, Inc. (Nsdaq: DCTH) has announced the appointment of J. Chris Houchins to the Company's clinical development team as Senior Vice President, Clinical and Medical Affairs. In this role, Mr. Houchins will be responsible for the development and implementation of clinical trial strategies for the Company's proprietary chemosaturation system and the development and management of relationships with medical societies, thought leaders, advocacy organizations, academic institutions, and health plans. Mr. Houchins will report directly to Krishna Kandarpa, MD, PhD, Executive Vice President, Research and Development and Chief Medical Officer. The appointment is effective immediately.
Houchins most recently served as the Chief Operating Officer and Sr. Vice President - Clinical Operations for Arno Therapeutics, Inc.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Houchins most recently served as the Chief Operating Officer and Sr. Vice President - Clinical Operations for Arno Therapeutics, Inc.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- AK Steel (AKS) Promotes Four to VP, SVP; Names New Raw Materials Engineering VP
- Edelman Financial (EF) Says Ric Edelman Becomes Sole CEO; Ball Remains Chairman
- QLT Inc. (QLTI) Says Nordic Biotech to Vote 7.4M Common in Favor of Nominees
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
